Zurko Research has completely revamped its website www.zurkoresearch.com adding new content and functionalities. The main novelty is the possibility of taking a virtual tour of its in vivo clinical trials laboratory. After having moved to new facilities early this year, the website visitors can now learn more about the equipment used to carry out Safety, Efficacy and SPF studies. Users of virtual reality glasses can even make the visit in first person.
The content of Zurko Research’s other areas of activity has also been expanded in this new website version. The Cosmetics area brings together the latest and most innovative claims, both in vivo and in vitro / ex vivo. The content of the Medical Devices, Regulatory Strategy and Biocides areas now also includes all the services that Zurko Research can offer to its clients.
Additionally, the new website also includes information on how to apply for a job position at the company and how to become a part of its database of panelists. Currently, Zurko has more than 7,000 registered panelists, who in exchange for participating in clinical trials receive financial remuneration and access to new products before their commercialization.
Zurko Research is a leading European CRO with more than 16 years of experience, specialized in in vivo, in vitro and ex vivo testing, as well as regulatory strategy consultancy services. Currently, the company carries out more than 7,000 clinical studies per year and has clients in 29 countries worldwide. It also holds different certifications, such as the UNE-EN-ISO 9001, UNE-EN IEC/ISO 17025 and CIR standards.
Sabina Giovannini
sabina.giovannini@zurkoresearch.com
Zurko Research SL Madrid
Ph. +34 91 521 15 88
Madrid: Avda. De la Osa Mayor,
4 28023 Madrid
Spain
Nanoparticles have a bad reputation among the general public. There is great uncertainty as to…
In an ever-changing and increasingly competitive hair care market, sensory profiling is a real asset…
Taobé Consulting specializes in helping cosmetic brands navigate complex European and UK regulatory frameworks, providing…